Poison and Drug info :  1-800-222-1222
Tucson Campus: 520-626-1427
Phoenix Campus: 602-827-2426

Jianqin Lu, BPharm, PhD

Assistant Professor, Pharmaceutics and Pharmacokinetics
Assistant Professor, BIO5 Institute
Member, NCI designated UA Comprehensive Cancer Center
Member, Southwest Environmental Health Sciences Center

Jianqin Lu, BPharm, PhD, is an Assistant Professor of Pharmaceutical Sciences in Pharmaceutics and Pharmacokinetics, at The University of Arizona College of Pharmacy. The overarching goal of the Lu lab is to apply synthetic chemistry, nanoparticle engineering, and tumor immunology to develop safe and efficacious nanotherapeutics to address the pressing unmet needs in current cancer therapy, particularly in the emerging field of combination immunochemotherapy. The Lu Lab's expertise in Pharmaceutics, Drug Delivery, Nanomedicine and Tumor Immunology paves the way to develop transformative and clinically translatable nanoimmunotherapeutics for combatting cancers. Dr. Lu was the recipient of the Norman R. and Priscilla A. Farnsworth Award at the University of Pittsburgh, and USHHS Ruth L. Kirschstein Institutional National Research Service Award in Tumor Immunology, among others.

Education & Post Graduate Training: 

Postdoc, Nanomedicine/Tumor Immunology, University of California, Los Angeles, 2019
Postdoc, Nanomedicine, The University of Chicago, Chicago, 2015
PhD, Pharmaceutics, University of Pittsburgh, Pittsburgh, 2014
BS, Pharmacy, Hunan University of Chinese Medicine, Changsha, China, 2010

Areas of Research: 

Drug Delivery
Nanomedicine
Pharmaceutics and Pharmacokinetics
Nano-ImmunoEngineering
Cancer Immunotherapy
Chemotherapy
Biomaterials

Types of Research:

Laboratory-based Research
Basic and Applied Sciences
Industry
Translational Medicine

Select Publications

2020

Wang Z, Chen J, Little N, Lu J. "Self-assembling Prodrug Nanotherapeutics for Synergistic Tumor Targeted Drug Delivery." Acta Biomater. 2020. PMCID: PMC7245299  PMID: 32454086

2017

Lu J, Liu X, Liao Y-P, et al. "Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression." Nat Commun. 2017;8(1):1811. PMCID: PMC5703845  PMID: 29180759

2015

Lu J, Liu C, Wang P, et al. "The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin." Biomaterials. 2015;62:176-87. PMCID: PMC4470812  PMID: 26057133

2014

Lu J, Zhao W, Liu H, et al. "An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance." J Control Release. 2014;196:272-86. PMCID: PMC4267990  PMID: 25456831

2013

Lu J, Huang Y, Zhao W, et al. "PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers." Biomaterials. 2013;34(5):1591-600. PMCID: PMC3529003  PMID: 23182923